Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Niessner

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
Annals of Hematology|May 1, 1991
Coincidence of acquired factor-X deficiency and disseminated intravascular coagulation in patients with acute nonlymphoblastic leukemiaI Pabinger, P Bettelheim, R Dudczak, et al.
Wiener Klinische Wochenschrift|April 3, 1987
[Oral anticoagulant therapy--renaissance of an old therapy?]K Lechner, C Korninger, P Kyrle, et al.
Thrombosis and Haemostasis|August 30, 1983
T-cell alterations in hemophiliacs treated with commercial clotting factor concentratesK Lechner, H Niessner, P Bettelheim, et al.
Acta Haematologica|January 1, 1986
Treatment of severe aplastic anemia with combined immunosuppression (antithymocyte globulin and high-dose methylprednisolone)M Hinterberger-Fischer, W Hinterberger, P Höckern, et al.
Wiener Klinische Wochenschrift|March 6, 1987
[Right heart failure as a clinical sign of pulmonary artery sarcoma]P Bettelheim, M Hochmeister, C Herold, et al.
Wiener Klinische Wochenschrift|October 15, 1982
[Bone marrow transplantation for aplastic anemia--initial results in 8 patients]W Hinterberger, H Gadner, P Höcker, et al.
Leukemia Research|October 10, 1998
Interferon-alpha for the treatment of elderly patients with chronic myeloid leukaemiaW Hilbe, U Apfelbeck, M Fridrik, et al.
Leukemia Research|January 1, 1997
Interferon-alpha-2C and LD ara-C for the treatment of patients with CML: results of the Austrian multi-center phase II studyJ Thaler, W Hilbe, U Apfelbeck, et al.
ESMO Open|August 3, 2024
Nomogram for predicting survival after first-line anti-PD-1-based immunotherapy in unresectable stage IV melanoma: a multicenter international studyE Chatziioannou, L M Serna Higuita, S Kreft, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|April 16, 2002
Traveller's thrombosis 2001H Partsch, H Niessner, L Bergau, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Annals of Hematology|May 1, 1991
Coincidence of acquired factor-X deficiency and disseminated intravascular coagulation in patients with acute nonlymphoblastic leukemiaI Pabinger, P Bettelheim, R Dudczak, et al.
Wiener Klinische Wochenschrift|April 3, 1987
[Oral anticoagulant therapy--renaissance of an old therapy?]K Lechner, C Korninger, P Kyrle, et al.
Thrombosis and Haemostasis|August 30, 1983
T-cell alterations in hemophiliacs treated with commercial clotting factor concentratesK Lechner, H Niessner, P Bettelheim, et al.
Acta Haematologica|January 1, 1986
Treatment of severe aplastic anemia with combined immunosuppression (antithymocyte globulin and high-dose methylprednisolone)M Hinterberger-Fischer, W Hinterberger, P Höckern, et al.
Wiener Klinische Wochenschrift|March 6, 1987
[Right heart failure as a clinical sign of pulmonary artery sarcoma]P Bettelheim, M Hochmeister, C Herold, et al.
Wiener Klinische Wochenschrift|October 15, 1982
[Bone marrow transplantation for aplastic anemia--initial results in 8 patients]W Hinterberger, H Gadner, P Höcker, et al.
Leukemia Research|October 10, 1998
Interferon-alpha for the treatment of elderly patients with chronic myeloid leukaemiaW Hilbe, U Apfelbeck, M Fridrik, et al.
Leukemia Research|January 1, 1997
Interferon-alpha-2C and LD ara-C for the treatment of patients with CML: results of the Austrian multi-center phase II studyJ Thaler, W Hilbe, U Apfelbeck, et al.
ESMO Open|August 3, 2024
Nomogram for predicting survival after first-line anti-PD-1-based immunotherapy in unresectable stage IV melanoma: a multicenter international studyE Chatziioannou, L M Serna Higuita, S Kreft, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|April 16, 2002
Traveller's thrombosis 2001H Partsch, H Niessner, L Bergau, et al.
Pageof 8